C.H. Robinson acquiring RXO in $5.8 billion stock and cash transaction
C.H. Robinson acquiring RXO in $5.8 billion stock and cash transaction Commercial Carrier Journal
Covered in this story
What has happened since
- Rxo Inc is down 0.4% since this was published.
- C.H. Robinson is down 4.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Rxo Inc
- BMO Capital Markets: $28.6 → $30.3 by Oct 2027 · Market Perform via Investing.com
- JPMorgan: $28.6 → $30 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $28.6 → $30.3 by Oct 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RXO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rxo Inc →Summary aggregated from Commercial Carrier Journal's public RSS feed. The full reporting belongs to Commercial Carrier Journal — please read it on their site.